MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma

Cancer Letters

Volumn 214, Issue 1, 2004, Pages 69-79

  Liu, Geoffrey ^a,b   Zhou, Wei ^a   Wang, Lisa I ^a   Park, Sohee ^a   Miller, David P ^a   Xu, Li Lian ^a   Wain, John C ^b   Lynch, Thomas J ^b   Su, Li ^a   Christiani, David C ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Gender; Lung cancer; MPO; Polymorphism; SOD2

Indexed keywords

ALANINE; ESTROGEN RECEPTOR; MANGANESE SUPEROXIDE DISMUTASE; MYELOPEROXIDASE; VALINE;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENZYME POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SEX DIFFERENCE; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PEROXIDASE; POLYMORPHISM, GENETIC; RISK FACTORS; SEX FACTORS; SUPEROXIDE DISMUTASE;

EID: 4344612582     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.06.027     Document Type: Article

References (53)

1. Y. Sun Free radicals, antioxidant enzymes, and carcinogenesis Free Radic. Biol. Med. 8 1990 583 599
2. L.J. Marnett Oxyradicals and DNA damage Carcinogenesis 21 2000 361 370
3. B.H. Robinson The role of manganese superoxide dismutase in health and disease J. Inherit. Metab. Dis. 21 1998 598 603
4. S.J. Klebanoff Myeloperoxidase: occurrence and biological function J. Everse K.E. Everse M.B. Grisham Peroxidases in Chemistry and Biology vol. 1 1991 CRC Press Boca Raton, FL 1 35
5. J.A. Williams Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression Carcinogenesis 22 2001 209 214
6. S. Shimoda-Matsubayashi, H. Matsumine, T. Kobayashi, Y. Nakagawa-Hattori, Y. Shimizu, and Y. Mizuno Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene Biochem. Biophys. Res. Commun. 226 1996 561 565
7. S. Hiroi, H. Harada, H. Nishi, M. Satoh, R. Nagai, and A. Kimura Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese Biochem. Biophys. Res. Commun. 261 1999 332 339
8. L.I. Wang, D.P. Miller, Y. Sai, G. Liu, L. Su, and J.C. Wain Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk J. Natl Cancer Inst. 93 2001 1818 1821
9. G.E. Austin, L. Lam, S.R. Zaki, W.C. Chan, T. Hodge, and J. Hou Sequence comparisons of putative regulatory DNA of the 5′ flanking region of the myeloperoxidase gene in normal and leukemic bone marrow cells Leukemia 7 1993 1445 1450
10. F.J. Piedrafita, R.B. Molander, G. Vansant, E.A. Orlova, M. Pfahl, and W.F. Reynolds An Alu element in the myeloperoxidase promoter contains a composite SPI-thyroid hormone-retinoic acid response element J. Biol. Chem. 271 1996 14412 14420
11. S.J. London, T.A. Lehman, and J.A. Taylor Myeloperoxidase genetic polymorphism and lung cancer risk Cancer Res. 57 1997 5001 5003
12. I. Cascorbi, S. Henning, J. Brockmuller, J. Gephart, C. Meisel, and J.M. Muller Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant -G463A of the myeloperoxidase gene Cancer Res. 60 2000 644 649
13. L. Le Marchand, A. Seifried, A. Lunn, and L.R. Wilkens Association of the myeloperoxidase -463G→A polymorphism with lung cancer risk Cancer Epidemiol., Biomarkers Prev. 9 2000 181 184
14. H. Dally, K. Gassner, B. Jager, P. Schmezer, B. Spiegelhalder, and L. Edler Myeloperoxidase (MPO) genotype and lung cancer histologic types: the MPO -463 A allele is associated with reduced risk for small cell lung cancer in smokers Int. J. Cancer 102 2002 530 535
15. A. Feyler, A. Voho, C. Bouchardy, K. Kuokkanen, P. Dayer, A. Hirvonen, and S. Benhamou Point: myeloperoxidase [-463]g→a polymorphism and lung cancer risk Cancer Epidemiol., Biomarkers Prev. 11 2002 1550 1554
16. O.H. Kantarci, T.G. Lesnick, P. Yang, R.L. Meyer, D.D. Hebrink, C.T. McMurray, and B.G. Weinshenker Myeloperoxidase -463 (G→A) polymorphism associated with lower risk of lung cancer Mayo Clin. Proc. 77 2002 17 22
17. W. Lu, D. Xing, J. Qi, W. Tan, X. Miao, and D. Lin Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population Int. J. Cancer 102 1992 275 279
18. M.B. Schabath, M.R. Spitz, W.K. Hong, G.L. Delclos, W.F. Reynolds, and G.B. Gunn A myeloperoxidase polymorphism associated with reduced risk of lung cancer Lung Cancer 37 2002 35 40
19. R.R. Misra, J.A. Tangrea, J. Virtamo, D. Ratnasinghe, M.R. Andersen, and M. Barrett Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland Cancer Lett. 164 2001 161 167
20. M.B. Schabath, M.R. Spitz, X. Zhang, G.L. Delclos, and X. Wu Genetic variants of myeloperoxidase and lung cancer risk Carcinogenesis 21 2001 1163 1166
21. L.L. Xu, G. Liu, D.P. Miller, W. Zhou, T.J. Lynch, and J.C. Wain Counterpoint: the myeloperoxidase -463G→a polymorphism does not decrease lung cancer susceptibility in Caucasians Cancer Epidemiol., Biomarkers Prev. 11 2002 1555 1559
22. X. Wu, M.B. Schabath, and M.R. Spitz Myeloperoxidase promoter region polymorphism and lung cancer risk Methods Mol. Med. 75 2003 121 133
23. W.F. Reynolds, M. Hiltunen, M. Pirskanen, A. Mannermaa, S. Helisalmi, and M. Lehtovirta MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish males Neurology 55 2000 1284 1290
24. U. Brockstedt, M. Krajinovic, C. Richer, G. Mathonnet, D. Sinnett, W. Pfau, and D. Labuda Analyses of bulky DNA adduct levels in human breast tissue and genetic polymorphisms of cytochromes P450 (CYPs), myeloperoxidase {MPO}, quinone oxidoreductase (NQO1), and glutathione S-transferases (GSTs) Mutat. Res. 516 2002 41 47
25. R. Fan, M.T. Wu, D.P. Miller, J.C. Wain, K.T. Kelsey, J.K. Wiencke, and D.C. Christiani The p53 codon 72 polymorphism and lung cancer risk Cancer Epidemiol., Biomarkers Prev. 9 2000 1037 1042
26. L.L. Xu, J.C. Wain, D.P. Miller, S.W. Thurston, L. Su, T.J. Lynch, and D.C. Christiani The NAD(P)H: quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior Cancer Epidemiol., Biomarkers Prev. 10 2001 303 309
27. W. Zhou, S.W. Thurston, G. Liu, L.L. Xu, D.P. Miller, and J.C. Wain The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer Cancer Epidemiol. Biomarkers Prev. 10 2001 461 466
28. D.P. Miller, G. Liu, I. De Vivo, T.J. Lynch, J.C. Wain, L. Su, and D.C. Christiani Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk Cancer Res. 62 2002 2819 2823
29. B. Bandy, and A.J. Davison Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Radic. Biol. Med. 8 1990 523 539
30. Z. Li, A. Khaletskiy, J. Wang, J.Y. Wong, L.W. Oberley, and J.J. Li Genes regulated in human breast cancer cells overexpressing manganese - containing superoxide dismutase Free Radic. Biol. Med. 30 2001 260 267
31. J.S. Rosenblum, N.B. Gilula, and R.A. Lerner On signal sequence polymorphisms and diseases of distribution Proc. Natl Acad. Sci. USA 93 1996 4471 4473
32. Y.C. Hong, K.H. Lee, C.H. Yi, E.H. Ha, and D.C. Christiani Genetic susceptibility of term pregnant women to oxidative damage Toxicol. Lett. 129 2002 255 262
33. M.B. Schabath, M.R. Spitz, G.L. Delclos, G.B. Gunn, L.W. Whitehead, and X. Wu Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk Am. J. Ind. Med. 42 2002 29 37
34. W.G. Mallet, D.R. Mosebrook, and M.A. Trush Activation of [+] trans-7,8-dihydroxy-7,8-dihydrobenzo-[a]-pyrene to diolepoxides by human polymorphonuclear leucocytes or myeloperoxidase Carcinogenesis 12 1991 521 524
35. F.F. Kadubar, M.A. Butler, K.R. Kaderlik, H.C. Chou, and N.P. Lang Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis Environ. Health Perspect. 98 1992 69 74
36. M. Rojas, R. Godschalk, K. Alexandrov, I. Cascorbi, E. Kriek, and J. Ostertag Myeloperoxidase - 463A variant reduces benzo[a]pyrene diol epoxide DNA adducts in skin of coal tar treated patients Carcinogenesis 22 2001 1015 1018
37. R.A. Clark, and S. Szot The myeloperoxidase-hydrogen peroxide-halide system as effector of neutrophil-mediated tumor cell cytotoxicity J. Immunol. 126 1981 1295 1301
38. C. Capeillere-Blandin, C. Martin, N. Gaggero, P. Pasta, G. Carrea, and S. Colonna Sulphoxidation reaction catalysed by myeloperoxidase from human leucocytes Biochem. J. 335 1998 27 33
39. N. Sugino, A. Karube-Harada, S. Kashida, S. Takiguchi, and H. Kato Differential regulation of copper-zinc superoxide dismutase and manganese superoxide dismutase by progesterone withdrawal in human endometrial stromal cells Mol. Hum. Reprod. 8 2002 68 74
40. O. Kabutomori, T. Yanagihara, Y. Iwatani, A. Kawarazaki, and M. Kabutomori Sex difference in myeloperoxidase activity of neutrophils Am. J. Hematol. 60 1999 312 313
41. G. Jansson Oestrogen-induced enhancement of myeloperoxidase activity in human polymorphonuclear leukocytes - a possible cause of oxidative stress in inflammatory cells Free Radic. Res. Commun. 14 1991 195 208
42. S.H. Zuckerman, and N. Bryan Inhibition of LDL oxidation and myeloperoxidase dependent tyrosyl radical formation by the selective estrogen receptor modulator raloxifene (LY139481 HCL) Atherosclerosis 126 1996 65 75
43. P.M. Tiidus, S. Zajchowski, D. Enns, D. Holden, E. Bombardier, and A.N. Belcastro Differential effect of oestrogen on post-exercise cardiac muscle myeloperoxidase and calpain activities in female rats Acta Physiol. Scand. 174 2002 131 136
44. R.M. Nagra, B. Becher, W.W. Tourtellotte, J.P. Antel, D. Gold, and T. Paladino Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis J. Neuroimmunol. 78 1997 97 107
45. W.F. Reynolds, J. Rhees, D. Maciejewski, T. Paladino, H. Sieburg, R.A. Maki, and E. Masliah Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease Exp. Neurol. 155 1999 31 41
46. P. Meisel, T. Krause, I. Cascorbi, W. Schroeder, F. Herrmann, U. John, and T. Kocher Gender and smoking-related risk reduction of periodontal disease with variant myeloperoxidase alleles Genes Immun. 3 2002 102 106
47. W.F. Reynolds, C.A. Stegeman, and J.W. Cohen Tervaert -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis Clin. Immunol. 103 2002 154 160
48. R.E. Harris, E.A. Zang, J.I. Anderson, and E.L. Wynder Race and sex differences in lung cancer risk associated with cigarette smoking Int. J. Epidemiol. 22 1993 592 599
49. H.A. Risch, G.R. Howe, M. Jain, J.D. Burch, E.J. Holowaty, and A.B. Miller Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type Am. J. Epidemiol. 138 1993 281 293
50. E.A. Zang, and E.L. Wynder Differences in lung cancer risk between men and women: examination of the evidence J. Natl Cancer Inst. 88 1996 183 192
51. M. Kreuzer, P. Boffetta, E. Whitley, W. Ahrens, V. Gaborieau, and J. Heinrich Gender differences in lung cancer risk by smoking: a multicentre case-control study in Germany and Italy Br. J. Cancer 82 2000 227 233
52. P.B. Bach, M.W. Kattan, M.D. Thornquist, M.G. Kris, R.C. Tate, and M.J. Barnett Variations in lung cancer risk among smokers J Natl Cancer Inst 95 2003 470 478
53. D.A. Hoy, B. Tregouet, O. Leininger-Muller, M. Poirier, C. Maurice, and G. Sass Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms Eur. J. Hum. Genet. 9 2001 780 786